Evidence map›Paper›PMID 34310761›Full record

ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2021

Assessing the responsiveness of sonographic biomarkers to Brodalumab therapy in Hidradenitis Suppurativa.

J W Frew, D Grand, K Navrazhina, S Garcet, J G Krueger

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the European Academy of Dermatology and Venereology : JEADV, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Interleukin-17 Inhibitors in the Treatment of Hidradenitis Suppurativa.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 2025
    Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

J W FrewLaboratory of Investigative Dermatology, Rockefeller University, NY, USA.ORCID https://orcid.org/0000-0001-5042-3632
D GrandLaboratory of Investigative Dermatology, Rockefeller University, NY, USA.
K NavrazhinaLaboratory of Investigative Dermatology, Rockefeller University, NY, USA.
S GarcetLaboratory of Investigative Dermatology, Rockefeller University, NY, USA.
J G KruegerLaboratory of Investigative Dermatology, Rockefeller University, NY, USA.

Funding

Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational SuccessUL1TR001866 · NCATS · ROCKEFELLER UNIVERSITY · PI COLLER, BARRY, KRUEGER, JAMES G · 2016 to 2025
$40.6M
NCATS NIH HHS UL1 TR001866NIGMS NIH HHS T32 GM007739NIGMS NIH HHS T32GM007739
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hidradenitis SuppurativaAntibodies, Monoclonal, HumanizedBiomarkersHumansUltrasonographyAntibodies, Monoclonal, HumanizedBiomarkersbrodalumab

Identifiers

PMID34310761
PMCPMC8595589

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.